Cargando…
BCG vaccine in Korea
The anti-tuberculosis Bacille de Calmette et Guérin (BCG) vaccine was developed between 1905 and 1921 at Pasteur Institutes of Lille in France, and was adopted by many countries. BCG strains comprise natural mutants of major virulence factors of Mycobacterium tuberculosis and that BCG sub-strains di...
Autores principales: | Joung, Sun Myung, Ryoo, Sungweon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710928/ https://www.ncbi.nlm.nih.gov/pubmed/23858398 http://dx.doi.org/10.7774/cevr.2013.2.2.83 |
Ejemplares similares
-
Complete Genome Sequence of Mycobacterium bovis BCG Korea, the Korean Vaccine Strain for Substantial Production
por: Joung, Sun Myung, et al.
Publicado: (2013) -
Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
por: Park, Sanghee, et al.
Publicado: (2022) -
BCG Vaccination
por: Miller, Russell
Publicado: (1953) -
The Current Status of BCG Vaccination in Young Children in South Korea
por: Lee, Hyejon, et al.
Publicado: (2012) -
BCG Vaccine—The Road Not Taken
por: Dow, Coad Thomas, et al.
Publicado: (2022)